Participate in a clinical trial for an FDA-approved narcolepsy drug

2024-05-24T13:29:40-07:00

The Treatment: XYWAV is an FDA-approved treatment for narcolepsy and Idiopathic Hypersomnia (IH). Study Aims: Assess the safety and efficacy of the treatment on sleepiness, polysomnography measurements (eg, sleep stage transitions, sleep patterns, and sleep quality), daytime and nighttime symptoms, pharmacokinetics (in narcolepsy), and patient-reported

Participate in a clinical trial for an FDA-approved narcolepsy drug2024-05-24T13:29:40-07:00

Participate in a Clinical Trial for an Ingestible Sleep Apnea Treatment

2024-05-24T13:07:41-07:00

Obstructive Sleep Apnea (OSA) is a common and serious sleep disorder in which breathing is repeatedly interrupted during sleep. OSA occurs when the airway collapses as you breathe in. This can cause breathing to be paused from several seconds to over a minute. While many

Participate in a Clinical Trial for an Ingestible Sleep Apnea Treatment2024-05-24T13:07:41-07:00